PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Inter-Dev Internet Marketing

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Drug Development Company Do-Coop Technologies Ltd Introduces Innovative Patented Nanotechnology System - Neowater® - An innovative patented Nanotechnology system has been developed by a Drug Development Company located in Israel. This technology has brought the drug development process into a completely new level
Drug Development Company Do-Coop Technologies Ltd Introduces Innovative Patented Nanotechnology System

 

NewswireToday - /newswire/ - Or Yehuda, Israel, 2008/10/29 - Neowater® - An innovative patented Nanotechnology system has been developed by a Drug Development Company located in Israel. This technology has brought the drug development process into a completely new level.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Pathogens evolve every day, and hence challenges met by the worldwide health care centers are tremendous. Therefore, one has to keep up with these fast and efficient techniques to identify infections as early as possible.

Do-coop Technologies Ltd. is a private company established in 1997 in Israel near Tel Aviv close to the Ben-Gurion International Airport. It has developed a patented Nanotechnology system to modify the properties of water using nanometer (one-billionth of a meter) size particles (Nano particles). This enables the first ever introduction of water-based biomaterials.

Neowater® is the first branded product of Do-coop, which targets the molecular diagnostics and research market within the Life Science industry. It is also offering new soluble service for Pharma and Biotech companies to enhance bioavailability and solubility of existing and new drugs. Do-coop qualifies for ISO 9001:2000 and ISO 14001:2004. The Neowater® technology is generated using a distinctive and innovated patented-process, challenges, and contemporary notions about water as well as the fundamental understanding of modern Physics.

Do-coop has the required proficiencies in the fields of Nanotechnology, Chemistry, Physics, and Biology. Neowater® has developed exceptional and half step PCR based kits for a rapid and consistent identification of various avian, feline and canine disease tests.

These kits are freeze free thus, the expense of shipping and storing are reduced, as it can be stored at room temperature. The diagnostic company such as Karnieli Ltd. presently uses Neowater®. To know more about Neowater® log on to the website. If you have queries or question you can log on to this site and you will receive a prompt reply from docoop.com. Docoop.com lets you know all the necessary information related to their current projects and services to other companies and detailed reports, supports, forums and media details.

Everyone loves to have a life of quality. Technology does go a long way in helping lead us a quality life, but sometimes one needs to have a superior technology to solve certain problems. Neowater® is a technology that will help you lead this quality life. On docoop.com, you can also join their research in their field of water physics and chemistry.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Inter-Dev Internet Marketing

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Drug Development Company Do-Coop Technologies Ltd Introduces Innovative Patented Nanotechnology System

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Docoop 
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Inter-Dev Internet Marketing securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Inter-Dev Internet Marketing / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Ipsen Announces Phase 3 CELESTIAL Trial of Cabozantinib Meets Primary Endpoint of Overall Survival
First Patient Treated with Microscopic Beads Pre-loaded with A Targeted Cancer Drug and Visible on CT Scans
BTG Plc Acquires Roxwood Medical
BTG and Mirada Medical Sign Three-Year Software Development Agreement
U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  RightITnow Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)